Veramarxgradient 36
Veramarxlogos icongrad 20  20solo

Veramarx, Inc.

Veramarx offers the only accurate diagnostic test for early-stage Lyme disease.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Boulder, CO, US
  • Currency USD
  • Founded January 2012
  • Employees 2
  • Incorporation Type C-corp
  • Website veramarx.com

Company Summary

Veramarx offers the only accurate diagnostic test for early-stage Lyme disease, which is one of the fastest growing infectious disease in the US and Western Europe. Lyme disease can only be treated effectively when diagnosed at the early stage of infection, when 75% of patients visit the doctor. Current tests are highly inaccurate, missing over 60% of the cases in the early stage.

Team

  • Whitney 20head 20shot 20copy
    Founder & Executive Chairman

    Whitney founded Veramarx because of his own experience with Lyme disease.

    Entrepreneur, M&A and financial services executive:
    ∞ CEO/General Manager, Aboca, USA
    ∞ CEO, Pop n’ Shake Development
    ∞ Structured Products Trader, Credit Suisse First Boston and 21st Securities
    ∞ Institutional Trader & Investment Advisory Board, West Peak Investment Advisors

  • B0180af0 4e31 44b3 a131 a3720c042f7e
    CEO upon closing series A round

    Mr. Macdonald has a strong track record of success with more than 25 years of international experience developing and commercializing clinical diagnostic products and laboratory services. Mr. Macdonald has served in CEO and COO roles for over 20 years, most recently as the CEO at Agendia, and formerly as a Division President, COO and Vice President at Quest Diagnostics.

Previous Investors